Clinical Trial Update: AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AIMSPRO in established diffuse cutaneous systemic sclerosis (systemic sclerosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• AIMSPRO

Snippet

Sponsor: Daval International Limited | Conditions: Systemic Sclerosis | Phase 2 | Status: UNKNOWN